Skip to main content
Premium Trial:

Request an Annual Quote

MolecularMD Receives CAP Accreditation for Cambridge NGS Laboratory

NEW YORK (GenomeWeb) – MolecularMD has received accreditation from the College of American Pathologists for its next-generation sequencing laboratory in Cambridge, Mass.

The accreditation follows CLIA certification of the lab earlier this year. Molecular MD opened the lab in 2012 to complement its RT-PCR and immunohistochemistry laboratory in Portland, Ore.

The company has developed NGS cancer panels on multiple platforms, specializing in tissue- and blood-based assays for retrospective evaluations and prospective clinical trial enrollment.

The NGS laboratory has validated methods and platforms for circulating tumor DNA analysis. It recently validated the Thermo Fisher Ion AmpliSeq Cancer Hotspot Panel v2 for the detection of somatic hotspot mutations with less than 1 percent allele frequency in ctDNA.

The company has also adopted Thermo Fisher's Oncomine Cancer Research panel for the analysis of mutations, copy number alterations, and fusions in cancer genomes.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.